Zacks Small Cap Research
@zackssmallcap.bsky.social
Zacks Small Cap Research provides equity research on #smallcap and #microcap firms. http://bit.ly/scr_disc
#SBC: 3Q25 Highlights - Strategies Aimed at Expanding Services & Footprint, Boosting Customer Average Revenue buff.ly/MiifxZM
November 21, 2025 at 7:14 PM
#SBC: 3Q25 Highlights - Strategies Aimed at Expanding Services & Footprint, Boosting Customer Average Revenue buff.ly/MiifxZM
#TRC: Investor Event Takeaways; Costly ‘25 Proxy Fight Likely Informs Company Willingness To Engage With Shareholders buff.ly/w1SPyLr
November 21, 2025 at 4:14 PM
#TRC: Investor Event Takeaways; Costly ‘25 Proxy Fight Likely Informs Company Willingness To Engage With Shareholders buff.ly/w1SPyLr
Zacks SCR has initiated coverage on Izotropic, developer of the #IzoView 3D Breast CT system. The report covers technology fundamentals, regulatory progress, business model, and key risks. #IZOZF #IZO #MedTech #SmallCaps #WomenHealth #BreastImaging #EquityResearch
youtu.be/gx3jEMsj5qU
youtu.be/gx3jEMsj5qU
IzoTropic Corporation: Developing a Better Breast Cancer Screening Device | $IZOZF $IZO
YouTube video by Zacks Investment Awareness
youtu.be
November 20, 2025 at 10:27 PM
Zacks SCR has initiated coverage on Izotropic, developer of the #IzoView 3D Breast CT system. The report covers technology fundamentals, regulatory progress, business model, and key risks. #IZOZF #IZO #MedTech #SmallCaps #WomenHealth #BreastImaging #EquityResearch
youtu.be/gx3jEMsj5qU
youtu.be/gx3jEMsj5qU
#CXW: Believe CXW is Positioned for Robust Growth; View Share Repurchase Increase as a Positive buff.ly/UDN6t0g
November 20, 2025 at 7:19 PM
#CXW: Believe CXW is Positioned for Robust Growth; View Share Repurchase Increase as a Positive buff.ly/UDN6t0g
#SNGX: Phase 3 FLASH2 Trial Enrolls 50th Patient; Interim Analysis in 2Q26 buff.ly/XGoMNe3
November 20, 2025 at 6:08 PM
#SNGX: Phase 3 FLASH2 Trial Enrolls 50th Patient; Interim Analysis in 2Q26 buff.ly/XGoMNe3
#RERE 3Q25 Earnings Review: EPS Beat on Higher Revenue & Operating Income; Operating Leverage Increasingly Shining Through buff.ly/nPnuEcU
November 20, 2025 at 5:08 PM
#RERE 3Q25 Earnings Review: EPS Beat on Higher Revenue & Operating Income; Operating Leverage Increasingly Shining Through buff.ly/nPnuEcU
#TBH: Transition via Dogecoin Related Merger Pending buff.ly/6ZdXh0E
November 20, 2025 at 2:39 PM
#TBH: Transition via Dogecoin Related Merger Pending buff.ly/6ZdXh0E
#QNRX: Several Recent Milestones - Cash Runway Extended into ‘27, Orphan Drug Designation Received, Positive Interim Data buff.ly/iOEDahS
November 20, 2025 at 2:17 PM
#QNRX: Several Recent Milestones - Cash Runway Extended into ‘27, Orphan Drug Designation Received, Positive Interim Data buff.ly/iOEDahS
#CPKF: Impressive Third Quarter Outshines Our EPS Estimate by $0.32 buff.ly/4MqwuU8
November 19, 2025 at 8:05 PM
#CPKF: Impressive Third Quarter Outshines Our EPS Estimate by $0.32 buff.ly/4MqwuU8
#NWTG: Newton Golf’s Strong Potential 2026 Revenue Growth Supports Price Target of $6.00 buff.ly/Uw5pwWf
November 19, 2025 at 7:11 PM
#NWTG: Newton Golf’s Strong Potential 2026 Revenue Growth Supports Price Target of $6.00 buff.ly/Uw5pwWf
#ARWR: REDEMPLO® Approved by FDA for the Treatment of FCS… buff.ly/ZosVrGT
November 19, 2025 at 5:19 PM
#ARWR: REDEMPLO® Approved by FDA for the Treatment of FCS… buff.ly/ZosVrGT
#LGMKD: New Device & Solutions Underlie 3Q & YTD Strong Revenue Improvements, as Additional New Features Launch buff.ly/dyyiexy
November 18, 2025 at 9:16 PM
#LGMKD: New Device & Solutions Underlie 3Q & YTD Strong Revenue Improvements, as Additional New Features Launch buff.ly/dyyiexy
#SUUN: First quarter results exceed expectations. Strong backlog counters headwinds in the Solar and BESS markets. buff.ly/xVaz2QS
November 18, 2025 at 7:09 PM
#SUUN: First quarter results exceed expectations. Strong backlog counters headwinds in the Solar and BESS markets. buff.ly/xVaz2QS
#BENF: F2Q26 Post-Earnings Recap: Moving Past Prior CEO-Related Issues; Focused on Simpler, More Transparent Business Model Going Forward buff.ly/29DHQjD
November 18, 2025 at 4:40 PM
#BENF: F2Q26 Post-Earnings Recap: Moving Past Prior CEO-Related Issues; Focused on Simpler, More Transparent Business Model Going Forward buff.ly/29DHQjD
#COCP: Phase 1b Norovirus Challenge Study of CDI-988 to Commence in 1Q26… buff.ly/6TyN701
November 18, 2025 at 4:22 PM
#COCP: Phase 1b Norovirus Challenge Study of CDI-988 to Commence in 1Q26… buff.ly/6TyN701
#AZTR: ATR-01 Data Presented buff.ly/BrQW8uX
November 18, 2025 at 2:48 PM
#AZTR: ATR-01 Data Presented buff.ly/BrQW8uX
#POET: Flush With Cash, POET Starts to Ship Production Orders in Q4 buff.ly/d3yGPPx
November 18, 2025 at 2:04 PM
#POET: Flush With Cash, POET Starts to Ship Production Orders in Q4 buff.ly/d3yGPPx
#CING: Third Quarter Results buff.ly/Qep5J7q
November 17, 2025 at 10:10 PM
#CING: Third Quarter Results buff.ly/Qep5J7q
#AMS: Equipment Upgrades, New O&O Centers Planned & Focus on Operational Efficiencies buff.ly/biAixON
November 17, 2025 at 9:16 PM
#AMS: Equipment Upgrades, New O&O Centers Planned & Focus on Operational Efficiencies buff.ly/biAixON
#HURA: Third Quarter Results buff.ly/cyZK53w
November 17, 2025 at 9:07 PM
#HURA: Third Quarter Results buff.ly/cyZK53w
#AEMD: Can Increased Treatments Extend, Further Improve Positive Patient Responses? buff.ly/hFqPLpp
November 17, 2025 at 7:29 PM
#AEMD: Can Increased Treatments Extend, Further Improve Positive Patient Responses? buff.ly/hFqPLpp
#DEFT 3Q25 Earnings Review: Revenue/EPS Miss on DeFi Alpha Delay buff.ly/jYCGjMg
November 17, 2025 at 7:28 PM
#DEFT 3Q25 Earnings Review: Revenue/EPS Miss on DeFi Alpha Delay buff.ly/jYCGjMg
#DYAI: Purchase Orders Rolling In buff.ly/kRetmOw
November 17, 2025 at 7:27 PM
#DYAI: Purchase Orders Rolling In buff.ly/kRetmOw
#ABEO: First Patient Treated with Zevaskyn® Pushed to 4Q25 Following Assay Optimization buff.ly/sgDUgVR
November 17, 2025 at 7:26 PM
#ABEO: First Patient Treated with Zevaskyn® Pushed to 4Q25 Following Assay Optimization buff.ly/sgDUgVR
#USEG: U.S. Energy Reports 3rd Quarter 2025 Financial & Operating Results buff.ly/BRGGZPR
November 17, 2025 at 7:25 PM
#USEG: U.S. Energy Reports 3rd Quarter 2025 Financial & Operating Results buff.ly/BRGGZPR